In Senate hearing: imported generic drugs facing consistent drug shortages need a government incentive program to help labs make life-saving commodity drugs domestically.
In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has made this particularly clear since the United States is now highly reliant on imported antibiotics and other lifesaving medications. The United States is so deep in the hole when it…
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
https://youtu.be/wLck3xmO4A8
Healthcare panelist and Phlow CEO Eric Edwards on what needs to be done to make more pharmaceutical drugs here. Most of them are coming in from Europe, India and…increasingly…China.
